title: Differences in imiquimod treatment outcome in two patients with bowenoid papulosis containing either episomal or integrated human papillomavirus 16.
authors.forename: Georges P H
authors.initials: GP
authors.lastname: Lucker
authors.forename: Ernst-Jan M
authors.initials: EJ
authors.lastname: Speel
authors.forename: David H K
authors.initials: DH
authors.lastname: Creytens
authors.forename: Adrienne J
authors.initials: AJ
authors.lastname: van Geest
authors.forename: Jolanda H M
authors.initials: JH
authors.lastname: Peeters
authors.forename: Sandra M H
authors.initials: SM
authors.lastname: Claessen
authors.forename: Anton H M
authors.initials: AH
authors.lastname: Vermeulen
authors.forename: Patrick
authors.initials: P
authors.lastname: Pauwels
authors.forename: Els V
authors.initials: EV
authors.lastname: Meulemans
mesh_terms: D000276:Adjuvants, Immunologic / Q000494:pharmacology*; D000328:Adult; D000368:Aged; D000634:Aminoquinolines / Q000494:pharmacology*; D052162:Human papillomavirus 16 / Q000378:metabolism*; D006801:Humans; D000077271:Imiquimod; D017403:In Situ Hybridization; D017404:In Situ Hybridization, Fluorescence; D008297:Male; D010409:Penile Diseases / Q000188:drug therapy* / Q000473:pathology* / Q000821:virology*; D010957:Plasmids / Q000378:metabolism*; D011230:Precancerous Conditions / Q000188:drug therapy* / Q000473:pathology / Q000821:virology; D016896:Treatment Outcome
chemical_list: D000276:Adjuvants, Immunologic; D000634:Aminoquinolines; D000077271:Imiquimod